ArticleTranslational andrology and urology2025

Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with low-volume, metastatic hormone-sensitive prostate cancer: a retrospective multicenter study.

Shaoxi Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.